Global Microbiome Sequencing Services Market: Snapshot
The global microbiome sequencing services market has experienced rapid growth in the last few years due to the growing support for research into genomics. The market has benefited from the growing investment being driven into the life sciences sector and particularly genetic and genomic research. Government healthcare agencies have been the prime contributor to the growth of the life sciences research sector, while private pharmaceutical and biotech companies have risen to the fore in recent year as a major contributor due to the growing economic potential of the sector. The microbiome sequencing services market is likely to benefit from the rising awareness about the utility of microbiome sequencing in understanding human health and how microbial presence affects it in various ways.
According to Transparency Market Research, the global microbiome sequencing services market is likely to rise to a valuation of US$1,570.4 mn by 2022. The microbiome sequencing services market was valued at US$684.1 mn in 2017 and is expected to exhibit a strong 18.1% CAGR between 2017 and 2022.
Sequencing by Synthesis Likely to Remain Favored Technique in Microbiome Sequencing
The global microbiome sequencing services market is segmented by technique into sequencing by synthesis, sequencing by ligation, pyrosequencing, Sanger sequencing, and others. Of these, sequencing by synthesis dominated the global microbiome sequencing services market in 2017, accounting for 47.8% of the global market with a valuation of US$326.7 mn. The segment is expected to exhibit an 18.6% CAGR in the 2017-2022 forecast period to rise to a valuation of US$765.6 mn by 2022. The promising growth prospects of the sequencing by synthesis segment are illustrated by the fact that its share in the global microbiome sequencing services market is likely to rise to 48.8% over the 2017-2022 forecast period.
North America to Dominate Global Microbiome Sequencing Services Market
Geographically, the global microbiome sequencing services market is dominated by North America, which held a valuation of US$261.4 mn in 2017 and is likely to rise to US$619.1 mn by 2022 thanks to an excellent 18.8% CAGR. The North America microbiome sequencing services market is helped by the presence of several leading players in the global pharmaceutical and biotech sector in the region, which has enabled a smooth growth in demand for microbiome sequencing services. The widespread awareness among consumers in North America about the utility of microbiome sequencing is also conducive to growth of the microbiome sequencing services market in the region.
Request a Brochure of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=28538
Europe is also likely to remain a leading contributor to the global microbiome sequencing services market in the coming years, with the market expected to rise to a valuation of US$439.5 mn by 2022. Europe is one of the regions where genomics research has continued largely unhindered, which has helped enable steady growth of the microbiome sequencing services market in the region. The Europe microbiome sequencing services market is likely to exhibit a strong 17% CAGR over the 2017-2022 forecast period.
Asia Pacific except Japan to Exhibit Robust 19.1% CAGR
Despite North America’s dominance in the global microbiome sequencing services market, Asia Pacific except Japan is likely to emerge as a major regional player in the global market in the coming years due to steady growth of the pharmaceuticals and biotech sector in the region. The APEJ market for microbiome sequencing services is likely to exhibit a 19.1% CAGR over the 2017-2022 forecast period to emerge at a valuation of US$245 mn by 2022.
The global microbiome sequencing services market is likely to remain fragmented in the coming years due to the availability of diverse opportunities in the market for players of all size. Leading players in the global microbiome sequencing services market include Metabiomics Corp., Microbiome Therapeutics LLC, Microbiome Insights Inc., Rancho Biosciences, Zymo Research Corp., Molzym GmbH & Co. KG, Ubiome Inc., Diversigen Inc., Merieux Nutrisciences Corporation, and Molecular Research LP.
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453